ERGO.L Share News (ERGO)

BROKER RATINGS SUMMARY: Jefferies And Exane BNP Downgrade M&S

Ergomed Issues Shares Under Bookrunner Option Exercises (ALLISS)

Ergomed To Acquire Haemostatix, To Raise Up To GBP13 Million (ALLISS)

Ergomed Profit More Than Doubles On Revenue And Margin Growth

Earnings, Trading Statements Calendar - Week Ahead

Earnings, Trading Statements Calendar - Week Ahead

Ergomed Confident For 2016 And Beyond As 2015 Revenue Up 25%

Ergomed Moves Finance Chief To New Role, Appoints New CFO

Ergomed Says Co-Development Partnerships Pipeline On Track

Ergomed Says Co-Development Partner Terminates Lung Cancer Trial

Ergomed Partner Aeterna Zentaris To Continue Phase 3 ZoptEC Study

Ergomed, Dilaforette Begin Phase II Sevuparin Trial

Ergomed To Up Contribution To CEL-SCI Head And Neck Cancer Trial

Ergomed doubles profits as contract revenues increase

(ShareCast News) - Ergomed has doubled its half year gross profit after increasing revenues from its clinical studies and pharmacovigilance contracts. The AIM-listed company, which provides specialised services to the pharmaceutical industry and develops new drugs, posted its half year results to 30

Ergomed Confident In Outlook As First Half Profit Rises